维普中文期刊产品整合服务
39篇 您的检索式:作者名="Bode B W"
    题名 作者 年代 出处 被引量
1Resveratrol-induced activa- tion of p53 and apoptosis ismediated by extracellular-signal-regula- ted protein kinases and p38 kinase 显示文摘She Q B Bode A M Ma W Y 2001Cancer Res2001,61,4:1
2Continous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetetes a randomiized, parallelgroup, 24-week study 显示文摘Raskin P Bode B W Marks J B 2003Diabetes Care2003,26,9:1
3Glucommander: A computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation 显示文摘Davidson P C Steed R D Bode B W 2005Diabetes Care2005,28,10:1
4Diabetes management in the millennium using insulin pump therapy 显示文摘Bode B W Sabbah H T Gross T M 2002Diabetes Metab Res Rev2002,18,1:1
5Effect of sitagliptin on post- prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled triM显示文摘Garg S K Moser E G Bode B W 2013Endocr Pract2013,19,1:1
6Sw itch to multiple daily injection with insulin glargine and lispro from eontinous subcutaneous insulin infusion with insulin lispro; a randomized, open-label study using a continous glucose monitoring system显示文摘Bode B W Steed R D Schleusener Ds etal 2005Endoer Pmct2005,11,3:1
7Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes 显示文摘 Steed RD Davidson PC 1996Diabetes Care1996,19,4:1
8Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in typel diabetes显示文摘BODE B W STEED R D DAVIDSON P C 1996Diabetes Care1996,19,:1
9Reduction in severe hypoglucaemia with long- term continuous subcutaneous insulin infusion in type 1 diabetes显示文摘Bode B W Stead R D Darison Pc 1996Diabetes Care1996,19,:1
10Use of the continuous glueoes monitoring system to guide therapy in patients with in sulin-treated diabetes: a randomized controlled trial显示文摘Tanenberg R Bode B Lane W 2004Mayo Clin Proc2004,79,:1
11Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes 显示文摘BODE B W TESTA M A MAGWIRE M 2010Diabetes Obesity and Metabolism2010,12,7:1
12Insu- lin glulisine compared to insulin aspart and to insulin lispro admin- istered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial显示文摘VAN BONA C BODE B W SERT LANGERON C 2011Diabetes Tech- nol Ther2011,13,6:1
13Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes显示文摘Sands Arthur T Zambrowicz Brian P Rosenstock Julio Lapuerta Pablo Bode Bruce W Garg Satish K Buse John B Banks Phillip Heptulla Rubina Rendell Marc Cefalu William T Strumph Paul 2015Diabetes Care2015,,7:1
14Efficacy safety and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes显示文摘Bode B W Strange P 2001Diabetes Care2001,24,1:1
15Resveratrol - induced activation of p53 and apoptosis is mediated by extracellular- signalregulated protein kinases and p38 kinase显示文摘She Q B Bode A M Ma W Y 2001Cancer Res2001,61,4:1
16Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2diabetes:a randomized,parallel-group,24-week study显示文摘Raskin P Bode B W Marks J B 2003Diabetes Care2003,26,9:1
17Diabetes management in the new millennium using insulin pump therapy显示文摘Bode B W Sabbah H T Gross T M 2002Diabetes Metab Res2002,18,9:1
18Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro; a randomized, open-label study using a continuous glucose monitoring system显示文摘Bode B W Steed R D Schleusener D S 2005Endocr Pmct2005,11,3:1
19Diabetes management in the new millennium using insulin pump therapy显示文摘Bode B W Sabbah H T Gross T M 2002Diabetes Metab Res Rev2002,18,1:1
20Swith to multiple daily injections with insulin glargine and insulin lispro from continous sub- cutaneous insulin infusion wih insulin lispro;arandomized, open-label study using a continuous glcose monitoring system 显示文摘Bode B W Steed R D Schteusener D S 2005Endocr Pmct2005,11,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费